Skip to main content
. Author manuscript; available in PMC: 2022 Oct 1.
Published in final edited form as: Genes Chromosomes Cancer. 2021 Jul 8;60(10):695–708. doi: 10.1002/gcc.22979

Table 2:

Summary of molecular results. AcCC: acinic cell carcinoma, AdCC: adenoid cystic carcinoma, CA-ex-PA: carcinoma ex pleomorphic adenoma, HCCC: hyalinizing clear cell carcinoma, IC: intraductal carcinoma, MEC: mucoepidermoid carcinoma, N/A: not assessed, PA: pleomorphic adenoma, SC: secretory carcinoma, SDC: salivary duct carcinoma.

Case Diagnosis RNA-Seq 5’ Gene
(NCBI Reference)
3’ Gene
(NCBI Reference)
FISH
1 PA PRB2-TAF15 * - - TAF15
2 PA Negative - - N/A
3 PA NPM1-PRB2 * 9 of 11 (NM_002520.6) 3 of 4 (NM_006248.3) Negative
4 PA DSTN-PLAG1 1 of 4 (NM_006870.3) 3 of 5 (NM_002655.2) PLAG1
5 PA CTNNB1-PLAG1 1 of 15 (NM_001904.3) 2 of 5 (NM_002655.2) N/A
6 PA CTNNB1-PLAG1 1 of 15 (NM_001904.3) 3 of 5 (NM_002655.2) N/A
7 PA HMGA2-WIF1 3 of 5 (NM_003483.4) 10 of 10 (NM_007191.4) N/A
8 PA HMGA2-WIF1 3 of 5 (NM_003483.4) 10 of 10 (NM_007191.4) N/A
9 PA Negative - - N/A
10 PA CTNNB1-PLAG1 1 of 15 (NM_001904.3) 3 of 5 (NM_002655.2) N/A
11 PA NTF3-PLAG1 1 of 2 (NM_001102654.1) 3 of 5 (NM_002655.2) PLAG1+
12 PA CTNNB1-PLAG1 1 of 15 (NM_001904.3) 3 of 5 (NM_002655.2) N/A
13 PA LIFR-PLAG1 1 of 20 (NM_002310.5) 3 of 5 (NM_002655.2) N/A
14 PA Negative - - N/A
15 PA Negative - - N/A
16 PA Negative - - N/A
17 PA Negative - - N/A
18 PA ACTA2- PLAG1 1 of 9 (NM_001613.4) 3 of 5 (NM_002655.3) N/A
19 PA NCALD- PLAG1 1 of 4 (NM_032041.2) 3 of 5 (NM_002655.2) N/A
20 PA HMGA2-WIF1 3 of 5 (NM_003483.4) 3 of 10 (NM_007191.4) N/A
21 PA CTNNB1-PLAG1 1 of 15 (NM_001904.3) 3 of 5 (NM_002655.2) N/A
22 PA CHCHD7-PLAG1 3 of 5 (NM_001011667.2) 3 of 5 (NM_002655.2) N/A
23 PA Negative - - N/A
24 PA NCALD-PLAG1 1 of 4 (NM_032041.2) 3 of 5 (NM_002655.2) PLAG1+
25 PA CTNNB1-PLAG1 1 of 15 (NM_001904.3) 3 of 5 (NM_002655.2) N/A
26 PA FBXO32-PLAG1 1 of 9 (NM_058229.3) 3 of 5 (NM_002655.2) PLAG1+
27 PA NCALD- PLAG1 1 of 4 (NM_032041.2) 3 of 5 (NM_002655.2) PLAG1+
28 CA-ex-PA FGFR1-PLAG1 2 of 18 (NM_023110.2) 3 of 5 (NM_002655.2) N/A
29 CA-ex-PA FBXO32-PLAG1 1 of 9 (NM_058229.3) 3 of 5 (NM_002655.2) PLAG1+
30 CA-ex-PA HMGA2-NFIB 3 of 5 (NM_003483.4) 9 of 11 (NM_001190737.1) N/A
31 CA-ex-PA MEG3-PLAG1 1 of 7 (NR_002766.2) 3 of 5 (NM_002655.2) PLAG1+
32 CA-ex-PA PLAG1-NFIB 1 of 5 (NM_002655.2) 3 of 11 (NM_001190737.1) PLAG1+, NFIB+
33 CA-ex-PA HMGA2-CNOT2 2 of 5 (NM_003483.4) 12 of 16 (NM_001199303.1) HMGA2 amplification
34 SDC-ex-PA Negative - - N/A
35 AdCC MYB-NFIB 13 of 16 (NM_001130173.1) 11 of 11 (NM_001190737.1) N/A
36 AdCC MYBL1-NFIB 14 of 16 (NM_001080416.3) 9 of 11 (NM_001190737.1) N/A
37 AdCC MYB-NFIB 15 of 16 (NM_001130173.1) 11 of 11 (NM_001190737.1) N/A
38 AdCC MYBL1-NFIB 8 of 16 (NM_001080416.3) 11 of 11 (NM_001190737.1) N/A
39 AdCC MYB-NFIB 15 of 16 (NM_001130173.1) 10 of 11 (NM_001282787.1) N/A
40 AdCC MYB-NFIB 15 of 16 (NM_001130173.1) 11 of 11 (NM_001190737.1) N/A
41 AdCC MYB-NFIB 15 of 16 (NM_001130173.1) 11 of 11 (NM_001190737.1) N/A
42 AdCC MYB-NFIB 13 of 16 (NM_001130173.1) 11 of 11 (NM_001190737.1) N/A
43 AdCC MYB-NFIB 8 of 16 (NM_001130173.1) 10 of 11 (NM_001282787.1) N/A
44 AdCC MYBL1-NFIB 8 of 16 (NM_001080416.3) 10 of 11 (NM_001282787.1) N/A
45 AdCC Negative - - N/A
46 AdCC MYB-NFIB 8 of 16 (NM_001130173.1) 11 of 11 (NM_001190737.1) N/A
47 AdCC MYB-NFIB 15 of 16 (NM_001130173.1) 11 of 11 (NM_001190737.1) N/A
48 AdCC MYB-NFIB 8 of 16 (NM_001130173.1) 11 of 11 (NM_001190737.1) N/A
49 AdCC MYB-NFIB 9 of 16 (NM_001130173.1) 11 of 11 (NM_001190737.1) N/A
50 AdCC MYBL1-NFIB 8 of 16 (NM_001080416.3) 9 of 11 (NM_001190737.1) N/A
51 AdCC NFIB-TBPL1 10 of 11 (NM_001190737.1) 7 of 7 (NM_001253676.1) NFIB+
52 AdCC MYBL1-NFIB 12 of 16 (NM_001080416.3) 2 of 11 (NM_001190737.1) N/A
53 AdCC MYB-NFIB 13 of 16 (NM_001130173.1) 11 of 11 (NM_001190737.1) N/A
54 AdCC MYBL1-VCPIP1 9 of 16 (NM_001080416.3) 3 of 3 (NM_025054.4) MYBL1+
55 MEC Negative - - MAML2+
56 MEC CRTC1-MAML2 2 of 14 (NM_015321.2) 1 of 5 (NM_032427.3) MAML2+
57 MEC Negative - - MAML2+
58 MEC CRTC3-MAML2 2 of 15 (NM_022769.4) 2 of 5 (NM_032427.3) MAML2+
59 MEC Negative - - Negative
60 MEC CRTC1-MAML2 2 of 14 (NM_015321.2) 1 of 5 (NM_032427.3) MAML2+
61 MEC CRTC1-MAML2 1 of 14 (NM_015321.2) 2 of 5 (NM_032427.3) MAML2+
62 MEC Negative - - MAML2+
63 MEC CRTC1-MAML2 1 of 14 (NM_015321.2) 2 of 5 (NM_032427.3) MAML2+
64 MEC Negative - - Negative
65 MEC CRTC3-MAML2 2 of 15 (NM_022769.4) 2 of 5 (NM_032427.3) MAML2+
66 MEC CRTC1-MAML2 1 of 14 (NM_015321.2) 2 of 5 (NM_032427.3) MAML2+
67 MEC CRTC1-MAML2 1 of 14 (NM_015321.2) 2 of 5 (NM_032427.3) MAML2+
68 MEC CRTC3-MAML2 2 of 15 (NM_022769.4) 2 of 5 (NM_032427.3) Negative
69 AcCC Negative - - N/A
70 AcCC Negative - - N/A
71 AcCC Negative - - N/A
72 AcCC Negative - - N/A
73 AcCC Negative N/A
74 HCCC EWSR1-ATF1 12 of 18 (NM_013986.3) 3 of 7 (NM_005171.4) N/A
75 HCCC Negative - - N/A
76 HCCC EWSR1-ATF1 14 of 18 (NM_013986.3) 5 of 7 (NM_005171.4) N/A
77 SC ETV6-NTRK3 5 of 8 (NM_001987.4) 15 of 20 (NM_001012338.2) N/A
78 SC ETV6-NTRK3 5 of 8 (NM_001987.4) 15 of 20 (NM_001012338.2) N/A
79 SDC RAPGEF6-ACSL6 1 of 29 (NM_001164386.1) 2 of 21 (NM_015256.3) N/A
80 IC NCOA4-RET 8 of 12 (NM_001145260.1) 12 of 20 (NM_020975.5) N/A

Stochastic events highlighted by an asterisk (*).